K Number
K112659

Validate with FDA (Live)

Date Cleared
2012-03-09

(178 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

This device is designed as an organ and tissue retractor for the use in minimally invasive surgical procedures to elevate organs and tissues to provide better access as well as visualization and stabilization of surgical sites.

Device Description

The Surgical Retractor is a Reusable device intended for mobilizing and maneuvering organ and tissue within the cavity during laparoscopic Surgical procedures.

AI/ML Overview

The provided text describes a 510(k) premarket notification for a "Surgical Retractor." This device is a reusable surgical instrument, not an AI/ML-driven device or a diagnostic tool that would typically have performance metrics like sensitivity, specificity, or accuracy, or require studies involving ground truth, expert readers, or training sets in the way the prompt describes.

Therefore, most of the requested information regarding acceptance criteria, study details, ground truth, and expert involvement is not applicable to this type of device and is not present in the provided documentation.

However, I can extract the relevant information from the document:

Device Type: Surgical Retractor (a physical, reusable surgical instrument).

Acceptance Criteria and Reported Device Performance:

Since this is a physical surgical instrument, the "acceptance criteria" are related to its functional and safety performance, implied by its "substantial equivalence" to predicate devices. The document does not provide specific numerical performance metrics for acceptance criteria and reported device performance. Instead, the device is deemed acceptable because it is substantially equivalent to legally marketed predicate devices.

Acceptance Criteria Category (Implied for Surgical Instruments)Reported Device Performance (Implied by Substantial Equivalence)
Intended Use: Mobilizing and maneuvering organs/tissue during laparoscopic procedures.Meets Intended Use: Designed as an organ and tissue retractor for use in minimally invasive surgical procedures to elevate organs and tissues to provide better access, visualization, and stabilization of surgical sites.
Material Compatibility & Biocompatibility: (Not explicitly stated in provided text, but assumed for surgical devices)(Implied to be acceptable based on predicate devices)
Sterilization & Reusability: (Device is stated as "Reusable")(Implied to be acceptable based on predicate devices and presumably verification testing as per manufacturing controls)
Mechanical Performance (e.g., strength, durability): (Not explicitly stated in provided text, but assumed for surgical devices)(Implied to be acceptable based on predicate devices and presumably verification testing as per manufacturing controls)
Safety: (Compatibility with surgical environment, lack of sharp edges causing unintended harm, etc.)(Implied to be acceptable based on predicate devices)

  • Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

    • Not applicable. The document does not describe a "test set" in the context of clinical data for performance evaluation in the way an AI/ML device would. Substantial equivalence for this type of device relies on comparisons to predicate devices and adherence to general controls, likely supported by engineering testing rather than clinical study data.
  • Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not applicable. "Ground truth" in the diagnostic/AI sense is not established for this type of device.
  • Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    • Not applicable.
  • If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not applicable. This device is a surgical instrument, not an AI-assisted diagnostic tool.
  • If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • Not applicable. This is a physical surgical instrument, not an algorithm.
  • The type of ground truth used (expert consensus, pathology, outcomes data, etc):

    • Not applicable.
  • The sample size for the training set:

    • Not applicable. This is a physical surgical instrument, not an AI/ML model requiring a training set.
  • How the ground truth for the training set was established:

    • Not applicable.

Summary of the study/submission for this device:

The "study" or justification for market clearance is based on the concept of substantial equivalence to legally marketed predicate devices. The submission (K112659) details that the "Surgical Retractor" is "substantially equivalent" to:

  • Laparoscopic Retractors (Diamond-Flex) (K092684) - Cardinal Health
  • Nathanson Liver Retractor (K942002) - Automated Medical Products
  • Endo-Retract (K914190) - Covidien

This substantial equivalence argument implies that the device performs as safely and effectively as these predicates for its intended use, and therefore meets the necessary regulatory "acceptance criteria" for a Class II medical device under 21 CFR 876.1500 (Endoscope and accessories, Product Code GCJ). The document does not detail specific performance studies beyond this declaration of equivalence.

{0}------------------------------------------------

K112659

9 2012

MAR - 9 2012

SECTION 5:

510(k) SUMMARY

Submitter:Surgical Innovations plc.Clayton Wood House6 Clayton Wood BankLeedsLS16 6QZUnited KingdomTel.: +44 (0)113 230-7597Fax: +44 (0)113 230-7598
Contact Person:Stephen SeedQuality Manager
Date SummaryPrepared:September 2011
Trade Name:Surgical Retractor
Common Name:Surgical Retractor
Classification Name:Laparoscope, General and Plastic Surgery(21 CFR 876.1500, Product Code GCJ)
Equivalent to:Laparoscopic Retractors (Diamond-Flex) (K092684) Cardinal HealthNathanson Liver Retractor (K942002) Automated Medical ProductsEndo-Retract (K914190) Covidien

Surgical Innovations Limited
Congical Innovations Limited
Corpor w

1


{1}------------------------------------------------

Device Description: The Surgical Retractor is a Reusable device intended for mobilizing and maneuvering organ and tissue within the cavity during laparoscopic Surgical procedures.

Intended Use:

This device is designed as an organ and tissue retractor for the use in minimally invasive surgical procedures to elevate organs and tissues to provide better access as well as visualization and stabilization of surgical sites.

Substantial Laparoscopic Retractors- Cardinal Health, Inc. (K092684) Equivalence: Nathanson Liver Retractor-Automated Medical Products (K942002) Endo-Retract- Covidien (K914190)

Surgical Innovations Limited

Clayton Wood House . 6 Clayton Wood Bank . Tel. +44(0)113 2307597 . Email. signing . Beg No. England 2298163
Leeds . LE E E E E ST reed? | 1216 602 Fax. +44(0)113 2307598 Web. www.surginno.com Wat Reg No. GB 519567317

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird with three wing-like shapes. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird symbol.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Surgical Innovations % Ms. Tracey Fearnley Clayton Wood House 6 Clayton Wood Bank Leeds LS166QZ United Kingdom

Re: K112659

Trade/Device Name: Surgical Retractor Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: GCJ Dated: March 2, 2012 Received: March 5, 2012

Dear Ms. Fearnley:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean r lease oe devised that I Dr. unation that your device complies with other requirements of the Act

MAR - 9 2012

{3}------------------------------------------------

Page 2 - Ms. Tracey Fearnley

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely vours.

for Mark N. Melkerson

Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

SECTION 4:

INDICATIONS FOR USE STATEMENT

n(k) Number (if known): Not known

  1. NOT KNOWN

evice Name:

Surgical Retractor

dications for Use

This device is designed as an organ and tissue retractor for the use in minimally invasive surgical procedures to elevate or retract organs and tissues to provide better access as well as visualization and stabilization of surgical sites.

cription Use_ r 21 CFR 801 Subpart D) AND/ OR

Over-The-Counter Use (Per 21 CFR 801 Subpart C)

(Please DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Neil R.P. Ogden for mx

Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number. K112659

gical Innovations Limited

ﺍﻟﻤﺴﺎﻋﺪ ﺍﻟﻤﺴﺎﻋﺪ ﺍﻟﻤﺴﺎﺣﺔ ﺍﻟﻤﺴﺎﻋﺪﺓ ﺍﻟﻤﺴﺎﻋﺪﺓ ﺍﻟﻤﺴﺎﻋﺪﺓ ﺍﻟﻤﺴﺎﻋﺪﺓ ﺍﻟﻤﺴﺎﻋﺪﺓ ﺍﻟﻤﺴﺎﻋﺪﺓ ﻣﻦ ﺍﻟﻤﺴﺎﻋﺪﺓ ﻣﻦ ﺍﻟﻤﺴﺎﻋﺔ ﺍﻟﻤﺴﺎﻋﺔ ﺍﻟﻤﺴﺎﻋﺔ - 1516 607 Fax. +44(0)113 2307598 Web. www.surginno.com Wat Reg No. GB 519567317 4-1

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.